Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NSAID + NALUFIN + local anesthetic + TAP Block refers to a multimodal analgesic protocol evaluated in clinical research for the management of postoperative pain following elective cesarean section. This regimen combines several pharmacological and regional anesthesia techniques: intravenous nalbuphine (marketed as Nalufin), which acts as a mixed opioid agonist-antagonist; local subcutaneous wound infiltration with a local anesthetic; and a Transversus Abdominis Plane (TAP) block, a regional anesthetic technique that targets the nerves of the anterior abdominal wall. Non-steroidal anti-inflammatory drugs (NSAIDs) are typically integrated into this protocol as rescue analgesia. The combination is designed to optimize pain control while potentially reducing the total opioid consumption and associated side effects in the postpartum period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NSAID + nalbuphine + local anesthetic + TAP block (Egymedicalpedia).